India revisits plans for free generic medicines, drug price fixing
Government hospitals in India that lack medicines, are overcrowded and understaffed, may soon be a thing of the past. Even as a thorough streamlining of systems is in the offing, in the distribution of free generic drugs and ensuring adequate staff at government health institutions, the Indian government is also readying to fix prices of patented drugs in the country, reports The Pharma Letter’s India correspondent.
An inter-ministerial committee of joint secretaries has been set up by the Indian government to suggest different ways to fix prices of patented drugs.
“The price of patented drugs is very high. Even if they are calculated on Gross National Income with purchasing power parity, most drug prices are way beyond the reach of the general masses,'' said a government official.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
More on this story...
Today's issue
Company Spotlight
More Features in Generics
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze